TickerFacts.

Nutex Health Inc. (NUTX): R&D Expense

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest R&D Expense is for the year ended 2021-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$285.9K
Year ended 2021-12-31
-19.4%
3-year compound annual growth
$768.1K2018-12-31: $545.2K2019-12-31: $768.1K2020-12-31: $557.3K2021-12-31: $285.9K$285.9K
2018-12-31 R&D Expense (USD) 2021-12-31
Period endedR&D ExpenseChange YoYSource filing
2021-12-31$285.9K-48.7%2022-03-31, From 2021-01-01
2020-12-31$557.3K-27.5%2022-03-31, From 2020-01-01
2019-12-31$768.1K+40.9%2021-04-05, From 2019-01-01
2018-12-31$545.2Kn/a2020-05-14, From 2018-01-01